Skip to main content
Erschienen in: American Journal of Clinical Dermatology 5/2006

01.10.2006 | Therapy in Practice

Role of Bacterial Superantigens in Atopic Dermatitis

Implications for Future Therapeutic Strategies

verfasst von: Ivan D. Cardona, Sang Hyun Cho, Dr Donald Y.M. Leung

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

The role of staphylococcal superantigens in the pathophysiology of atopic dermatitis (AD) has been the focus of intense interest during the past decade. Although the increased prevalence of Staphylococcus aureus and its bacterial toxins in AD skin is well established, exploitation of the known mechanisms of superantigens in this disease for the development of novel therapies remains an active area of research. With the emergence of multi-drug resistant S. aureus, the need for a better understanding of the pathophysiology of bacterial superantigens in AD has become increasingly important. This review examines the mechanisms of S. aureus colonization and infection, of which the most important are defective skin barrier function, increased S. aureus adherence, and the decreased innate immune responses found in AD skin. The contribution of superantigens to the pathophysiology of AD is then discussed. Important immunologic mechanisms in this context include the role of superantigens in promoting T helper-2 skin inflammation, IgE production, T-regulatory cell subversion, expansion and migration of skin-homing T cells, and IgE anti-superantigen production. Lastly, these findings are discussed with reference to current therapeutic approaches, of which the most important include anti-inflammatory and antimicrobial medications, and future strategies, which are expected to consist of immune-modulators and synthetic antibacterials.
Literatur
1.
Zurück zum Zitat Leung DY, Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993 Dec 4; 342 (8884): 1385–8PubMedCrossRef Leung DY, Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993 Dec 4; 342 (8884): 1385–8PubMedCrossRef
2.
Zurück zum Zitat Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974 May; 90 (5): 525–30PubMedCrossRef Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974 May; 90 (5): 525–30PubMedCrossRef
3.
Zurück zum Zitat Dahl MV. Staphylococcus aureus and atopic dermatitis. Arch Dermatol. 1983 Oct; 119 (10): 840–6PubMedCrossRef Dahl MV. Staphylococcus aureus and atopic dermatitis. Arch Dermatol. 1983 Oct; 119 (10): 840–6PubMedCrossRef
4.
Zurück zum Zitat Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol. 1977 Jun; 113 (6): 780–2PubMedCrossRef Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol. 1977 Jun; 113 (6): 780–2PubMedCrossRef
5.
Zurück zum Zitat Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 Jun 1; 248 (4959): 1066PubMed Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 Jun 1; 248 (4959): 1066PubMed
6.
Zurück zum Zitat Hank PJ, Hamid QA, Chrousos GP, et al. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol. 2000 Apr; 105 (4): 782–7CrossRef Hank PJ, Hamid QA, Chrousos GP, et al. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol. 2000 Apr; 105 (4): 782–7CrossRef
7.
Zurück zum Zitat Hank PJ, Leung DY. Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis?. J Allergy Clin Immunol. 2001 Feb; 107 (2): 391–2CrossRef Hank PJ, Leung DY. Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis?. J Allergy Clin Immunol. 2001 Feb; 107 (2): 391–2CrossRef
8.
Zurück zum Zitat Bax R, Bywater R, Cornaglia G, et al. Surveillance of antimicrobial resistance: what, how and whither?. Clin Microbiol Infect. 2001 Jun; 7 (6): 316–25PubMedCrossRef Bax R, Bywater R, Cornaglia G, et al. Surveillance of antimicrobial resistance: what, how and whither?. Clin Microbiol Infect. 2001 Jun; 7 (6): 316–25PubMedCrossRef
9.
Zurück zum Zitat Heritage J, Wilcox M, Sandoe J. Antimicrobial resistance potential. Lancet. 2001 Sep 29; 358 (9287): 1099–100PubMedCrossRef Heritage J, Wilcox M, Sandoe J. Antimicrobial resistance potential. Lancet. 2001 Sep 29; 358 (9287): 1099–100PubMedCrossRef
10.
Zurück zum Zitat Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005 May; 5 (5): 275–86PubMedCrossRef Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005 May; 5 (5): 275–86PubMedCrossRef
11.
Zurück zum Zitat Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005 Apr 7; 352 (14): 1436–44PubMedCrossRef Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005 Apr 7; 352 (14): 1436–44PubMedCrossRef
12.
13.
Zurück zum Zitat Chu D, Haake A, Holbrook K, et al. The structure and development of skin. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 2003: 58–88 Chu D, Haake A, Holbrook K, et al. The structure and development of skin. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 2003: 58–88
14.
Zurück zum Zitat Leung DY. Atopic dermatitis and the immune system: the role of superantigens and bacteria. J Am Acad Dermatol. 2001 Jul; 45 (1 Suppl.): S13–6PubMedCrossRef Leung DY. Atopic dermatitis and the immune system: the role of superantigens and bacteria. J Am Acad Dermatol. 2001 Jul; 45 (1 Suppl.): S13–6PubMedCrossRef
15.
Zurück zum Zitat Cho SH, Strickland I, Boguniewicz M, et al. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol. 2001 Aug; 108 (2): 269–74PubMedCrossRef Cho SH, Strickland I, Boguniewicz M, et al. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol. 2001 Aug; 108 (2): 269–74PubMedCrossRef
16.
Zurück zum Zitat Akiyama H, Hamada T, Huh WK, et al. Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in skin lesions of buttons impetigo, atopic dermatitis and pemphigus foliaceus. Br J Dermatol. 2003 Mar; 148 (3): 526–32PubMedCrossRef Akiyama H, Hamada T, Huh WK, et al. Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in skin lesions of buttons impetigo, atopic dermatitis and pemphigus foliaceus. Br J Dermatol. 2003 Mar; 148 (3): 526–32PubMedCrossRef
17.
Zurück zum Zitat Morishita Y, Tada J, Sato A, et al. Possible influences of Staphylococcus aureus on atopic dermatitis: the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy. 1999 Aug; 29 (8): 1110–7PubMedCrossRef Morishita Y, Tada J, Sato A, et al. Possible influences of Staphylococcus aureus on atopic dermatitis: the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy. 1999 Aug; 29 (8): 1110–7PubMedCrossRef
18.
Zurück zum Zitat Arikawa J, Ishibashi M, Kawashima M, et al. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum comeum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol. 2002 Aug; 119 (2): 433–9PubMedCrossRef Arikawa J, Ishibashi M, Kawashima M, et al. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum comeum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol. 2002 Aug; 119 (2): 433–9PubMedCrossRef
19.
Zurück zum Zitat Mempel M, Schmidt T, Weidinger S, et al. Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J Invest Dermatol. 1998 Sep; 111 (3): 452–6PubMedCrossRef Mempel M, Schmidt T, Weidinger S, et al. Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J Invest Dermatol. 1998 Sep; 111 (3): 452–6PubMedCrossRef
20.
Zurück zum Zitat Postlethwaite AE, Hotness MA, Katai H, et al. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992 Oct; 90 (4): 1479–85PubMedCrossRef Postlethwaite AE, Hotness MA, Katai H, et al. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992 Oct; 90 (4): 1479–85PubMedCrossRef
21.
Zurück zum Zitat Christophers E, Henseler T. Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res. 1987; 279 Suppl.: S48–51PubMedCrossRef Christophers E, Henseler T. Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res. 1987; 279 Suppl.: S48–51PubMedCrossRef
22.
Zurück zum Zitat Grice K, Sattar H, Baker H, et al. The relationship of transepidermal water loss to skin temperature in psoriasis and eczema. J Invest Dermatol. 1975 May; 64 (5): 313–5PubMedCrossRef Grice K, Sattar H, Baker H, et al. The relationship of transepidermal water loss to skin temperature in psoriasis and eczema. J Invest Dermatol. 1975 May; 64 (5): 313–5PubMedCrossRef
23.
Zurück zum Zitat Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003 Sep 15; 171 (6): 3262–9PubMed Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003 Sep 15; 171 (6): 3262–9PubMed
24.
Zurück zum Zitat Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002 Oct 10; 347 (15): 1151–60PubMedCrossRef Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002 Oct 10; 347 (15): 1151–60PubMedCrossRef
25.
Zurück zum Zitat Gallo RL, Murakamt M, Ohtake T, et al. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol. 2002 Dec; 110 (6): 823–31PubMedCrossRef Gallo RL, Murakamt M, Ohtake T, et al. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol. 2002 Dec; 110 (6): 823–31PubMedCrossRef
26.
Zurück zum Zitat Howell MD, Novak N, Bieber T, et al. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol. 2005 Oct; 125 (4): 738–45PubMedCrossRef Howell MD, Novak N, Bieber T, et al. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol. 2005 Oct; 125 (4): 738–45PubMedCrossRef
27.
Zurück zum Zitat Laouini D, Kawamoto S, Yalcindag A, et al. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol. 2003 Nov; 112 (5): 981–7PubMedCrossRef Laouini D, Kawamoto S, Yalcindag A, et al. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol. 2003 Nov; 112 (5): 981–7PubMedCrossRef
28.
Zurück zum Zitat Lin YT, Wang CT, Hsu CT, et al. Differential susceptibility to staphylococcal superantigen (SsAg)-induced apoptosis of CD4+ T cells from atopic dermatitis patients and healthy subjects: the inhibitory effect of IL-4 on SsAg-induced apoptosis. J Immunol. 2003 Jul 15; 171 (2): 1102–8PubMed Lin YT, Wang CT, Hsu CT, et al. Differential susceptibility to staphylococcal superantigen (SsAg)-induced apoptosis of CD4+ T cells from atopic dermatitis patients and healthy subjects: the inhibitory effect of IL-4 on SsAg-induced apoptosis. J Immunol. 2003 Jul 15; 171 (2): 1102–8PubMed
29.
Zurück zum Zitat Leung DY, Soler NA. Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol. 2001 Jan; 44 (1 Suppl.): S1–12PubMedCrossRef Leung DY, Soler NA. Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol. 2001 Jan; 44 (1 Suppl.): S1–12PubMedCrossRef
30.
Zurück zum Zitat Travers JB, Norris DA, Leung DY. The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc. 2001 Dec; 6 (3): 225–30PubMedCrossRef Travers JB, Norris DA, Leung DY. The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc. 2001 Dec; 6 (3): 225–30PubMedCrossRef
31.
Zurück zum Zitat Yarwood JM, Leung DY, Schlievert PM. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol Lett. 2000 Nov 1; 192 (1): 1–7PubMedCrossRef Yarwood JM, Leung DY, Schlievert PM. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol Lett. 2000 Nov 1; 192 (1): 1–7PubMedCrossRef
32.
Zurück zum Zitat Zollner TM, Wichelhaus TA, Hartung A, et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy. 2000 Jul; 30 (7): 994–1000PubMedCrossRef Zollner TM, Wichelhaus TA, Hartung A, et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy. 2000 Jul; 30 (7): 994–1000PubMedCrossRef
33.
Zurück zum Zitat Taskapan MO, Kumar P. Role of staphylococcal superantigens in atopic dermatitis: from colonization to inflammation. Ann Allergy Asthma Immunol. 2000 Jan; 84 (1): 3–10PubMedCrossRef Taskapan MO, Kumar P. Role of staphylococcal superantigens in atopic dermatitis: from colonization to inflammation. Ann Allergy Asthma Immunol. 2000 Jan; 84 (1): 3–10PubMedCrossRef
34.
Zurück zum Zitat Strickland I, Hauk PJ, Trumble AE, et al. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol. 1999 Feb; 112 (2): 249–53PubMedCrossRef Strickland I, Hauk PJ, Trumble AE, et al. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol. 1999 Feb; 112 (2): 249–53PubMedCrossRef
35.
Zurück zum Zitat Bunikowski R, Mielke M, Skarabis H, et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol. 1999 Jan; 103 (1 Pt 1): 119–24PubMedCrossRef Bunikowski R, Mielke M, Skarabis H, et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol. 1999 Jan; 103 (1 Pt 1): 119–24PubMedCrossRef
36.
Zurück zum Zitat Leung DY, Hank P, Strickland I, et al. The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol. 1998 Dec; 139 Suppl. 53: 17–29PubMedCrossRef Leung DY, Hank P, Strickland I, et al. The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol. 1998 Dec; 139 Suppl. 53: 17–29PubMedCrossRef
37.
Zurück zum Zitat Bunikowski R, Mielke ME, Skarabis H, et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol. 2000; 105: 814–9PubMedCrossRef Bunikowski R, Mielke ME, Skarabis H, et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol. 2000; 105: 814–9PubMedCrossRef
38.
39.
Zurück zum Zitat Carlsson R, Fischer H, Sjogren HO. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol. 1988 Apr 15; 140 (8): 2484–8PubMed Carlsson R, Fischer H, Sjogren HO. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol. 1988 Apr 15; 140 (8): 2484–8PubMed
40.
Zurück zum Zitat Breuer K, Kapp A, Werfel T. Bacterial infections and atopic dermatitis. Allergy. 2001 Nov; 56 (11): 1034–41PubMedCrossRef Breuer K, Kapp A, Werfel T. Bacterial infections and atopic dermatitis. Allergy. 2001 Nov; 56 (11): 1034–41PubMedCrossRef
41.
Zurück zum Zitat Nomura I, Tanaka K, Tomita H, et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol. 1999 Aug; 104 (2 Pt 1): 441–6PubMedCrossRef Nomura I, Tanaka K, Tomita H, et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol. 1999 Aug; 104 (2 Pt 1): 441–6PubMedCrossRef
42.
Zurück zum Zitat Tomi NS, Kranke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy controls. J Am Acad Dermatol. 2005; 53: 67–72PubMedCrossRef Tomi NS, Kranke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy controls. J Am Acad Dermatol. 2005; 53: 67–72PubMedCrossRef
43.
Zurück zum Zitat Yagi S, Wakaki N, Ikeda N, et al. Presence of staphylococcal exfoliative toxin A in sera of patients with atopic dermatitis. Clin Exp Allergy. 2004; 34: 984–93PubMedCrossRef Yagi S, Wakaki N, Ikeda N, et al. Presence of staphylococcal exfoliative toxin A in sera of patients with atopic dermatitis. Clin Exp Allergy. 2004; 34: 984–93PubMedCrossRef
44.
Zurück zum Zitat Strange P, Skov L, Lisby S, et al. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol. 1996 Jan; 132 (1): 27–33PubMedCrossRef Strange P, Skov L, Lisby S, et al. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol. 1996 Jan; 132 (1): 27–33PubMedCrossRef
45.
Zurück zum Zitat Skov L, Olsen JV, Giomo R, et al. Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigenmediated mechanism. J Allergy Clin Immunol. 2000 Apr; 105 (4): 820–6PubMedCrossRef Skov L, Olsen JV, Giomo R, et al. Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigenmediated mechanism. J Allergy Clin Immunol. 2000 Apr; 105 (4): 820–6PubMedCrossRef
46.
Zurück zum Zitat Michie CA, Davis T. Atopic dermatitis and staphylococcal superantigens. Lancet. 1996 Feb 3; 347 (8997): 324PubMedCrossRef Michie CA, Davis T. Atopic dermatitis and staphylococcal superantigens. Lancet. 1996 Feb 3; 347 (8997): 324PubMedCrossRef
47.
Zurück zum Zitat Wachs GN, Maibach HI. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis. Br J Dermatol. 1976 Sep; 95 (3): 323–8PubMedCrossRef Wachs GN, Maibach HI. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis. Br J Dermatol. 1976 Sep; 95 (3): 323–8PubMedCrossRef
48.
Zurück zum Zitat Lever R, Hadley K, Downey D, et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol. 1988 Aug; 119 (2): 189–98PubMedCrossRef Lever R, Hadley K, Downey D, et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol. 1988 Aug; 119 (2): 189–98PubMedCrossRef
49.
Zurück zum Zitat Saloga J, Leung DY, Reardon C, et al. Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T-cell-dependent inflammatory response. J Invest Dermatol. 1996 May; 106 (5): 982–8PubMedCrossRef Saloga J, Leung DY, Reardon C, et al. Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T-cell-dependent inflammatory response. J Invest Dermatol. 1996 May; 106 (5): 982–8PubMedCrossRef
50.
Zurück zum Zitat Herz U, Schnoy N, Borelli S, et al. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production. J Invest Dermatol. 1998 Mar; 110 (3): 224–31PubMedCrossRef Herz U, Schnoy N, Borelli S, et al. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production. J Invest Dermatol. 1998 Mar; 110 (3): 224–31PubMedCrossRef
51.
Zurück zum Zitat Zollner TM, Munk ME, Keller T, et al. The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes. Immunol Lett. 1996 Jan; 49 (1-2): 111–6PubMedCrossRef Zollner TM, Munk ME, Keller T, et al. The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes. Immunol Lett. 1996 Jan; 49 (1-2): 111–6PubMedCrossRef
52.
Zurück zum Zitat Leung DY, Gately M, Trumble A, et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med. 1995 Feb 1; 181 (2): 747–53PubMedCrossRef Leung DY, Gately M, Trumble A, et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med. 1995 Feb 1; 181 (2): 747–53PubMedCrossRef
53.
Zurück zum Zitat Abemalhy-Carver KJ, Sampson HA, Picker LJ, et al. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest. 1995 Feb; 95 (2): 913–8CrossRef Abemalhy-Carver KJ, Sampson HA, Picker LJ, et al. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest. 1995 Feb; 95 (2): 913–8CrossRef
54.
Zurück zum Zitat Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest. 2004 Mar; 113 (5): 651–7PubMed Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest. 2004 Mar; 113 (5): 651–7PubMed
55.
Zurück zum Zitat Mangan DF, Robertson B, Wahl SM. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol. 1992 Mar 15; 148 (6): 1812–6PubMed Mangan DF, Robertson B, Wahl SM. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol. 1992 Mar 15; 148 (6): 1812–6PubMed
56.
Zurück zum Zitat Bratton DL, May KR, Kailey JM, et al. Staphylococcal toxic shock syndrome toxin-1 inhibits monocyte apoptosis. J Allergy Clin Immunol. 1999 May; 103 (5 Pt 1): 895–900PubMedCrossRef Bratton DL, May KR, Kailey JM, et al. Staphylococcal toxic shock syndrome toxin-1 inhibits monocyte apoptosis. J Allergy Clin Immunol. 1999 May; 103 (5 Pt 1): 895–900PubMedCrossRef
57.
Zurück zum Zitat On LS, Goleva E, Hall C, et al. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol. 2004 Apr; 113 (4): 756–63CrossRef On LS, Goleva E, Hall C, et al. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol. 2004 Apr; 113 (4): 756–63CrossRef
58.
Zurück zum Zitat Hofer MF, Harbeck RJ, Schlievert PM, et al. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol. 1999 Feb; 112 (2): 171–6PubMedCrossRef Hofer MF, Harbeck RJ, Schlievert PM, et al. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol. 1999 Feb; 112 (2): 171–6PubMedCrossRef
59.
Zurück zum Zitat Hofer MF, Lester MR, Schlievert PM, et al. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Allergy. 1995 Dec; 25 (12): 1218–27PubMedCrossRef Hofer MF, Lester MR, Schlievert PM, et al. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Allergy. 1995 Dec; 25 (12): 1218–27PubMedCrossRef
60.
Zurück zum Zitat Lester MR, Hofer MF, Renz H, et al. Modulatory effects of staphylococcal superantigen TSST-1 on IgE synthesis in atopic dermatitis. Clin Immunol Immunopathol. 1995 Dec; 77 (3): 332–8PubMedCrossRef Lester MR, Hofer MF, Renz H, et al. Modulatory effects of staphylococcal superantigen TSST-1 on IgE synthesis in atopic dermatitis. Clin Immunol Immunopathol. 1995 Dec; 77 (3): 332–8PubMedCrossRef
61.
Zurück zum Zitat Neuber K, Steinrucke K, Ring J. Staphylococcal enterotoxin B affects in vitro IgE synthesis, interferon-gamma, interleukin-4 and interleukin-5 production in atopic eczema. Int Arch Allergy Immunol. 1995 May-Jun; 107 (1-3): 179–82PubMedCrossRef Neuber K, Steinrucke K, Ring J. Staphylococcal enterotoxin B affects in vitro IgE synthesis, interferon-gamma, interleukin-4 and interleukin-5 production in atopic eczema. Int Arch Allergy Immunol. 1995 May-Jun; 107 (1-3): 179–82PubMedCrossRef
62.
Zurück zum Zitat Leung DY, Harbeck R, Bina P, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest. 1993 Sep; 92 (3): 1374–80PubMedCrossRef Leung DY, Harbeck R, Bina P, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest. 1993 Sep; 92 (3): 1374–80PubMedCrossRef
63.
Zurück zum Zitat Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association ‘Administrative Regulations for Evidence-Based Clinical Practice Guidelines’. J Am Acad Dermatol. 2004 Mar; 50 (3): 391–404PubMedCrossRef Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association ‘Administrative Regulations for Evidence-Based Clinical Practice Guidelines’. J Am Acad Dermatol. 2004 Mar; 50 (3): 391–404PubMedCrossRef
64.
Zurück zum Zitat Leung DY, Nicklas RA, Li JT, et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol. 2004 Sep; 93 (3 Suppl. 2): S1–21PubMedCrossRef Leung DY, Nicklas RA, Li JT, et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol. 2004 Sep; 93 (3 Suppl. 2): S1–21PubMedCrossRef
65.
Zurück zum Zitat Boguniewicz M, Sampson H, Leung SB, et al. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. J Allergy Clin Immunol. 2001 Oct; 108 (4): 651–2PubMedCrossRef Boguniewicz M, Sampson H, Leung SB, et al. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. J Allergy Clin Immunol. 2001 Oct; 108 (4): 651–2PubMedCrossRef
66.
Zurück zum Zitat Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol. 1998 Dec; 139 Suppl. 53: 13–6PubMedCrossRef Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol. 1998 Dec; 139 Suppl. 53: 13–6PubMedCrossRef
67.
Zurück zum Zitat Yoshimura M, Namma S, Akamatsu H, et al. Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol. 1996 Oct; 135 (4): 528–32PubMedCrossRef Yoshimura M, Namma S, Akamatsu H, et al. Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol. 1996 Oct; 135 (4): 528–32PubMedCrossRef
68.
Zurück zum Zitat Stalder JF, Fleury M, Sourisse M, et al. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol. 1994 Oct; 131 (4): 536–40PubMedCrossRef Stalder JF, Fleury M, Sourisse M, et al. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol. 1994 Oct; 131 (4): 536–40PubMedCrossRef
69.
Zurück zum Zitat Nilsson E, Henning C, Hjorleifsson ML. Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J Am Acad Dermatol. 1986 Aug; 15 (2 Pt 1): 192–7PubMedCrossRef Nilsson E, Henning C, Hjorleifsson ML. Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J Am Acad Dermatol. 1986 Aug; 15 (2 Pt 1): 192–7PubMedCrossRef
70.
Zurück zum Zitat Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol. 1992 Jul; 27 (1): 29–34PubMedCrossRef Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol. 1992 Jul; 27 (1): 29–34PubMedCrossRef
71.
Zurück zum Zitat Pournaras CC, Lubbe J, Samat JH. Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (FK506). J Invest Dermatol. 2001 Mar; 116 (3): 480–1PubMedCrossRef Pournaras CC, Lubbe J, Samat JH. Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (FK506). J Invest Dermatol. 2001 Mar; 116 (3): 480–1PubMedCrossRef
72.
Zurück zum Zitat Remitz A, Kyllonen H, Granlund H, et al. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol. 2001 Jan; 107 (1): 196–7PubMedCrossRef Remitz A, Kyllonen H, Granlund H, et al. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol. 2001 Jan; 107 (1): 196–7PubMedCrossRef
73.
Zurück zum Zitat Polano MK, De Vries HR. Analysis of the results obtained in the treatment of atopic dermatitis with corticosteroid-and neomycin-containing ointments. Dermatologica. 1960 Apr; 120: 191–9PubMedCrossRef Polano MK, De Vries HR. Analysis of the results obtained in the treatment of atopic dermatitis with corticosteroid-and neomycin-containing ointments. Dermatologica. 1960 Apr; 120: 191–9PubMedCrossRef
74.
Zurück zum Zitat Li L, Goleva E, Hall CF, et al. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J Allergy Clin Immunol. 2004 Nov; 114 (5): 1059–69PubMedCrossRef Li L, Goleva E, Hall CF, et al. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J Allergy Clin Immunol. 2004 Nov; 114 (5): 1059–69PubMedCrossRef
75.
Zurück zum Zitat Savage PB, Li C, Taotafa U, et al. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol Lett. 2002 Nov 19; 217 (1): 1–7PubMedCrossRef Savage PB, Li C, Taotafa U, et al. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol Lett. 2002 Nov 19; 217 (1): 1–7PubMedCrossRef
76.
Zurück zum Zitat Schlievert PM. Will therapeutic peptides be kryptonite for superantigens?. Nat Med. 2000 Apr; 6 (4): 378–9PubMedCrossRef Schlievert PM. Will therapeutic peptides be kryptonite for superantigens?. Nat Med. 2000 Apr; 6 (4): 378–9PubMedCrossRef
Metadaten
Titel
Role of Bacterial Superantigens in Atopic Dermatitis
Implications for Future Therapeutic Strategies
verfasst von
Ivan D. Cardona
Sang Hyun Cho
Dr Donald Y.M. Leung
Publikationsdatum
01.10.2006
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 5/2006
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200607050-00001

Weitere Artikel der Ausgabe 5/2006

American Journal of Clinical Dermatology 5/2006 Zur Ausgabe

Therapy in Practice

Persistent Acne in Women

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.